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Abstract
USH2A variants are the most common cause of Usher syndrome type 2, characterized by congenital sensorineural hearing
loss and retinitis pigmentosa (RP), and also contribute to autosomal recessive non-syndromic RP. Several treatment
strategies are under development; however, sensitive clinical trial endpoint metrics to determine therapeutic efficacy have
not been identified. In the present study, we have performed longitudinal retrospective examination of the retinal and
auditory symptoms in (i) 56 biallelic molecularly confirmed USH2A patients and (ii) ush2a mutant zebrafish to identify
metrics for the evaluation of future clinical trials and rapid preclinical screening studies. The patient cohort showed a
statistically significant correlation between age and both rate of constriction for the ellipsoid zone length and
hyperautofluorescent outer retinal ring area. Visual acuity and pure tone audiograms are not suitable outcome measures.
Retinal examination of the novel ush2au507 zebrafish mutant revealed a slowly progressive degeneration of predominantly
rods, accompanied by rhodopsin and blue cone opsin mislocalization from 6 to 12 months of age with lysosome-like
structures observed in the photoreceptors. This was further evaluated in the ush2armc zebrafish model, which revealed
similar changes in photopigment mislocalization with elevated autophagy levels at 6 days post fertilization, indicating a
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Introduction
Usher syndrome, characterized by combined sensorineural hear-
ing loss and retinitis pigmentosa (RP), is the most common cause
of deaf-blindness worldwide (1,2). Three clinical types (Usher
syndrome types 1, 2 and 3) can be distinguished based on the
severity and progression of the hearing loss and presence or
absence of vestibular dysfunction, with type 1 being the most
severe and type 2 (USH2) being the most frequent (2). Mutations
in USH2A (MIM #608400) are the most frequent cause of Usher
syndrome, accounting for up to 85% of USH2 cases, as well as
causing up to 23% of non-syndromic autosomal recessive RP (3).
There is a broad USH2A mutation spectrum with the two most
common variants located in exon 13 (i) c.2299delG, p.(Glu767fs)
and (ii) c.2276G>T, p.(Cys759Phe) (4–6). USH2A encodes usherin,
a 5202 amino acid transmembrane protein with domains com-
mon to extracellular matrix proteins and cell adhesion proteins,
including several predicted laminin domains and fibronectin III
repeats. A short secreted isoform of 1546 amino acid in size
is also expressed in various tissues, including intestine and
testis, but the full-length protein is thought to be predominantly
expressed in the retina and cochlea (7,8).
In the retina, usherin co-localizes with the two other known
USH2-related proteins, adhesion G protein-coupled receptor V1
(ADGRV1) and whirlin, at the periciliary membrane (8–10). This
structure is thought to be involved in docking and fusion of
transport vesicles that contain cargo bound for the photore-
ceptor connecting cilium and outer segment. Usherin is also
known to interact with other Usher proteins, including har-
monin (USH1C), myosin VIIa (USH1B) and SANS (USH1G) in
the photoreceptors (9,11–13). In the mammalian cochlea, an
USH2 complex consisting of usherin, ADGRV1 and whirlin, forms
the transient ankle links between adjacent stereocilia of the
developing hair cell bundles (14,15). These links are thought to
play a role in regulating stereociliary growth, differentiation and
organization during postnatal development.
USH2 is characterized by moderate-to-severe congenital
sensorineural hearing loss with normal vestibular function.
Usher syndrome-associated visual impairment is the result
of RP and presents with night blindness (nyctalopia) and
loss of peripheral visual field caused by rod photorecep-
tor degeneration, progressing to involve cones leading to
central vision loss, often resulting in legal blindness (16).
There is significant intra- and inter-familial phenotypic
variability, which has recently also been reflected in ush2a
zebrafish disease models (10,17). The full-length zebrafish
ush2a gene (transcript ID. ENSDART00000086201.5) consists
of 72 exons (15 708 bp of coding sequence) and encodes the
usherin protein, which shares 52% identity and 68% similarity
to the human orthologue. CRISPR/Cas9 generated mutants
ush2armc1 [c.2337_2342delinsAC; p.(Cys780Glnfs∗32) in exon 13]
and ush2ab1245 [c.15520_15523delinsTG; p.(Ala5174fs∗) in exon
71] revealed defective electroretinogram (ERG) responses at
5 days post fertilization (dpf) and photoreceptor cell death
following exposure to constant bright light (3000 lux) for
72 h at 8 dpf (10). However, examination at adult ages
was limited and did not reveal clear progressive abnormal-
ities. In contrast, a TALENs-generated ush2ahzu6 zebrafish
[c.136_152delGCCCCTCAGGGCAACTT; p.(Ala46Profs∗10), exon
1] was described as showing early defects in ERG and acoustic
startle responses with a progressive rod-cone degeneration in
the adult fish, apparent from 12 months due to shortening of the
photoreceptor outer segments (17). Levels of rod-specific pro-
teins rhodopsin, GNAT1 and GNB1 were reduced from 7 months.
While hearing loss in patients can be ameliorated with the
use of hearing aids or cochlear implants, there is currently
no treatment available to prevent the RP-induced vision loss.
Several therapies are in preclinical development including small
molecule drugs (18), CRISPR/Cas9-based genome editing (19) and
antisense oligonucleotides (20,21). Little is known about suitable
outcome measures for USH2 prospective clinical trials due to
limited clinical longitudinal natural history studies in the litera-
ture. In this study, we have explored the long-term USH2A patho-
physiology in humans and examined the molecular defects
underlying USH2A-associated retinal degeneration in a novel
zebrafish mutant [ush2au507; c.2131_2203+73delinsCGGCGG;
p.(Ala711fs∗), exon 12; transcript ID: XM_009293147.3] and the
previously published ush2armc1 mutant, to further improve
our understanding of the molecular pathology underlying the
disease and to identify potential outcome measures for assaying
a response to emerging therapeutics in both preclinical and
clinical studies.
Results
Molecular and clinical characteristics of patients
To investigate clinical trial outcome measures for USH2A-related
retinal disease, patients with molecularly confirmed biallelic
USH2A mutations (n = 56, average age 40 years, range 15–66 at
first visit) were retrospectively assessed. Collectively they dis-
played 67 distinct variants including 19 nonsense variants, 29
missense variants, 16 frameshift-inducing indels and 3 variants
affecting pre-mRNA splicing (Fig. 1 and Supplementary Material,
Table S1). Among these variants, the following were previously
unreported: c.5555A>G p.(His1852Arg), c.7789A>T p.(Lys2597∗),
c.7883dupC p.(Pro2628Profs∗7) and c.11156G>T p.(Arg3719Leu).
There was a strong agreement in best-corrected visual acuities
(BCVA) between eyes with a net bias of 0.05 decimal acuity units
and a 95% confidence interval of +0.41 to −0.37 (Fig. 2A and B).
There was a strong statistical correlation between acuity at
baseline and 2 year follow-up (r2 = 0.815, P < 0.0001) with little
change in BCVA. Only 23 of 56 patients had any change in visual
acuity between first and last visits (range: +0.25 to −0.5 decimal
units).
Longitudinal changes in hyperautofluorescent ring
area and ellipsoid zone length
All patients displayed a hyperautofluorescent (hyperAF) outer
ring phenotype, better described as elliptical rather than circular
(r2 = 0.99 versus 0.95), with the vertical diameter on average
363 μm shorter than horizontal. At baseline, 53/56 patients had
the classic dual hyper/hypoAF rings (the remaining four patients
had only hyperAF rings at baseline); this decreased to 52 patients
at time point 1 and to 48 patients by time point 2. The loss of the
hypoAF ring phenotype occurred in subjects with the least ring
area at baseline and likely correlated with insufficient residual
retina to produce the dual ring phenotype. The hyperAF ring
was the more stable and repeatable metric, and thus followed
for longitudinal trends. Size of the hyperAF ring was biphasic
with a very rapid decline in area over the first ∼ 30 years of
life, then becoming much less steep in the following decades
of life. For instance, the average ring area for <30 years old was
20.1 mm2 (range 63.13–1.14 mm2) compared to 6.96 mm2 (range
38.26–0.18 mm2) for those >30 years of age. The reduction in
hyperAF area is highly variable across all ages (Fig. 2E). The aver-
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Figure 1. Position and type of USH2A variants in participating patients. Schematic diagram of the usherin protein domain architecture and USH2A exon structure. The
genetic position and type of mutation of the identified USH2A variants in the patients within this study are presented as lollypops at the corresponding location in the
usherin protein. Black labels correspond to nonsense mutations, white labels correspond to missense variants, diagonal lines correspond to splice site variants and
grey labels correspond to insertion and deletion frameshift changes. LamGL, laminin globular-like domain; LamNT, N-terminal laminin domain; LamEGF, laminin-type
epidermal growth factor-like domains; FN3, fibronectin III domains; TM, transmembrane domain; PDZ, PDZ-binding domain.
for the first follow-up period and slowed only slightly to
1.01 mm2 (range 6.06–0.01 mm2) for the second follow-up period.
The rates were only weakly correlated between the two time
points (r2 = 0.22, P = 0.001) (Fig. 2F).
Ellipsoid zone (EZ) length compared to age follows a non-
linear function (Fig. 2C), which is not well described by loga-
rithmic or multiphasic declines as there is no clear inflection
point. The average EZ length for the under 30 cohort was 3534 μm
(±1449 μm SD), while the over 50 subjects had a residual EZ
length of 1653 (±679 μm SD). However, discrete analysis shows
that the decline is faster at younger rather than at older ages
linked to the finite amount of residual retina. The rate of con-
striction follows a similar pattern to residual length, although
there is a clear inflection point at about 30 years of age (Fig. 2D).
For instance, average degeneration rate in subjects under 30
was 204 μm/year (range of 36–659 μm/year). The >50 years of
age cohort showed the average constriction rate dropped to
112 μm/year (range 48–257 μm/year). Mean change in retinal
thickness was 7.7 μm/year (range: +151.9 to −98.1 μm/year),
but measurements were confounded by macular edema and
therefore not consistent with the retinal degeneration (Supple-
mentary Material, Fig. S2).
In order to design a trial for an inherited retinal disease
using systemic-delivered therapies, such as small molecule drug
ataluren (TranslarnaTM), a factor which predicts future progres-
sion must be developed. This is in contrast to surgical interven-
tion for conventional viral gene therapies in which the fellow
eye can be used as an internal control. When we evaluate the
prediction of follow-up period 1 versus 2 for the EZ length, the
values are significantly correlated (r2 = 0.207, P = 0.001) (Fig. 3A).
This improves if hyperAF ring constriction rate is used (r2 = 0.227,
P = 0.0008) (Fig. 3B), but this can be absent in advanced cases
(22). While both of these are statistically significant due to the
number of patients in this study, neither correlation singularly
accounts for the majority of variability in the data. Therefore,
more complex relationships need to be evaluated in order to
attempt to design a study for USH2. If a multimodal approach
is adopted using the ratio of EZ and hyperAF rates, a highly
significant relationship is seen (r2 = 0.44, P < 0.0001) (Fig. 3C).
Degree and progression of hearing loss
There were 11 patients with retrospectively available audiomet-
ric information (Supplementary Material, Table S2). All patients
(except patient 6, who was progressive from severe to profound
from first to third decade of life) had moderate to severe hearing
loss when tested at any age with relatively stable hearing levels
when the audiogram was repeated (Fig. 4). Audiometric config-
uration showed 10 patients had high frequencies hearing loss
(i.e. more prominent hearing loss at frequencies above 2000 Hz).
Patient 59 had a stable flat configuration of their hearing loss at
all time points from their first to third decade. All patients had
symmetrical hearing loss between both right and left ears.
No genotype–phenotype correlation could be ascertained due
to compound heterozygosity and small numbers. Patient 6 with
severe progressive hearing loss had compound heterozygous
mutations: c.2299delG, p.(Glu767Serfs21∗) and c.14911C>T,
p.(Arg4971∗). The variant c.2299delG was identified in seven
other cases with non-progressive hearing loss, while the
c.14911C>T variant (found only in this case) was not found
to be significantly associated with progressive hearing loss
(P = 0.25, Fischer’s exact test). Patient 59, the only case with
the flat configuration of hearing loss had mutations at
c.920_923dupGCCA (p.His308Glnfs) and c.3518C>A, p.(Ser1173∗),
which were not found in other patients.
Reduced visual function in ush2a u507 zebrafish
The CRISPR/Cas9 generated ush2au507 mutant line carried a
146 bp deletion in exon 12 and the following intron with
a 6 bp insertion; c.2131_2203+73delinsCGGCGG, p.(Ala711fs),
verified using Sanger sequencing (Fig. 5B). On transcript level,
this deletion results in the exclusion of exon 12 from the
ush2a mRNA, resulting in a frameshift and premature stop
codon. Using an antibody directed against the C-terminus,
usherin was shown to be expressed in the photoreceptors of
5 days post fertilization (dpf) wild-type (wt) zebrafish retina
where it localized adjacent to the connecting cilium marker
centrin (Fig. 5C). Usherin was not detected in the ush2au507
retina. RNAscope assay revealed notably reduced levels of ush2a
mRNA in the adult ush2au507 photoreceptors (outer nuclear layer
[ONL]) compared to wt, indicative of nonsense-mediated decay
(Supplementary Material, Fig. S4).
To assess visual function in ush2au507 larvae, ERG responses
were recorded from zebrafish at 5 dpf (Fig. 6A). The ERG maxi-
mum b-wave amplitudes were found to be significantly reduced
in ush2au507 larvae as compared to wt controls (P < 0.01; wt n = 69,
ush2au507 n = 67) (Fig. 6B). Visual function was also tested in adult
zebrafish using optokinetic response testing but was not found
to be statistically significant at any age (Fig. 6C); at 3, 6 and
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Figure 2. Visual acuity, EZ and hyperautofluorescent (hyperAF) ring measurements with age in USH2A patients. (A) and (B) Change in visual acuity over the observation
period. (A) illustrates the change in BCVA between baseline and final follow up. The grey dashed line represents ‘no change’ while the black correlation line illustrates
the subtle change. The measurement of each patient at each visit is depicted as a function of age in (B). (C) Correlation between EZ length and age. (D) EZ constriction
rate (change in size divided by time between visits) as a function of age. Both (C) and (D) illustrate that the degeneration starts rapidly with later, slower decline. (E) and
(F) illustrate the same changes in hyperAF ring area.
cycles per degree (cpd), respectively, in ush2au507 compared to
0.80 ± 0.16, 1.06 ± 0.20 and 1.13 ± 0.17 cpd in wt (n ≥ 4).
No gross abnormalities were noted on retinal histology up
to 6 months post fertilization (mpf), but a significant differ-
ence (P < 0.01) in the number of ONL nuclei in ush2au507 fish
was seen at 12 mpf (80.1 ± 4.99) compared to age-matched wt
fish (102.1 ± 8.29) (n = 5) (Supplementary Material, Fig. S5). Cell
death assays showed a significant increase in apoptotic pho-
toreceptor nuclei per retinal section with age in the ush2au507
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Figure 3. Inter-relatedness of progression between metrics. While there is a
strong correlation between the rate of change observed in the first and second
observation periods for both EZ length constriction (A) and hyperautofluores-
cence (hyperAF) ring constriction (B), neither correlation line describes the data
well (r2 = 0.207 and 0.227 respectively). The ratio of EZ length and hyperAF ring
constriction accounts for a much greater share of the variability (C, r2 = 0.4355).
respectively; n ≥ 13, P < 0.001), while apoptotic nuclei were only
detected in the 12 mpf wt retina (0.22 ± 0.22; n = 10) (Supple-
mentary Material, Fig. S5). Apoptosis levels were significantly
elevated at 6 and 12 mpf in the mutant compared to wt (P < 0.05
and P < 0.01, respectively).
Structure and function of the mechanosensory hair
cells in ush2a u507 zebrafish
The localization of usherin was examined in the macular hair
cells of 6 dpf zebrafish, using an N-terminal usherin antibody. In
the wt hair cells, expression of usherin was concentrated at the
region of the stereociliary hair bundles while specific expression
was not detected in the ush2au507 larval macula (Fig. 7A and B). A
similar expression pattern was observed in wt and mutant neu-
romasts (Supplementary Material, Fig. S6). The development of
the anterior macula was examined in 6 dpf ush2au507 larvae using
phalloidin staining (Fig. 7C and D). The hair bundles appeared
slightly thinner in width and showed a mild but significant
(P < 0.05) reduction in number in the mutant larvae compared
to wt (61.90 ± 1.20 versus 67.6 ± 1.11, n = 10) (Fig. 7E).
Acoustic startle response testing was used to assess audi-
tory function in 5 dpf larvae (Fig. 7F). When exposed to audi-
tory stimuli of 100, 300, 600, 900 and 1200 Hz, ush2au507 fish
moved a mean distance of 15.4 ± 0.86, 11.9 ± 0.80, 23.7 ± 1.48,
17.0 ± 0.95 and 17.2 ± 1.01 mm (n = 88), respectively, compared to
9.7 ± 0.65, 13.9 ± 1.00, 22.1 ± 1.41, 20.8 ± 1.33 and 21.5 ± 1.25 mm
in wt (n = 77), respectively. The differences in response between
wt and ush2au507 larvae were not found to be statistically signif-
icant.
Using scanning electron microscopy, the development of the
neuromast hair cells was assessed by examining the ultrastruc-
tural morphology at 6 dpf (Supplementary Material, Fig. S6). In
the wt hair cells, stereociliary hair bundles can be identified
as tiers of stereocilia in staircase-like arrangements associated
with a much longer kinocilium. In the ush2au507 neuromasts,
stereocilia appear to be fewer and less well-organized within
their bundles. Using FM1–43FX dye uptake to assess vesicle
endocytosis in wt and ush2au507 neuromasts did not reveal sig-
nificant differences (Supplementary Material, Fig. S6).
Opsin mislocalization and autophagy defects in the
ush2a mutant retina
Rhodopsin was found to be mislocalized to the rod photore-
ceptor cell body in the ush2au507 mutant at 6 and 12 mpf,
with significantly reduced protein expression levels by 26.8%
(P < 0.01) and 35.9% (P < 0.05), respectively, compared to wt
(n = 3) (Fig. 8A–D and U). Localization of the cone opsins was
also assessed in the mutant retina (Fig. 8E–T). At 6 mpf, all cone
opsins showed normal localization in both wt and ush2au507
retina. By 12 mpf, blue opsin showed accumulation in the blue
cone inner segments in the ush2au507 retina. There did not appear
to be notable differences in UV, red and green opsin localization
between the wt and mutant retinas at the ages examined.
Transmission electron microscopy was used to examine the
retinal ultrastructure at 6 mpf, revealing patches of rod photore-
ceptor loss and cellular debris amongst mostly preserved areas
of the ush2au507 retina (Fig. 9A and B). In addition, atypical vesic-
ular structures, thought to be lysosomes, were noted around
the photoreceptor inner and outer segment boundary and the











egen user on 26 O
ctober 2020
Human Molecular Genetics, 2020, Vol. 29, No. 11 1887
Figure 4. Degree and progression of hearing loss in USH2A patients. Pure tone average (PTA) measurements (decibel hearing loss, dB HL) from right (R) and left (L) ears
of USH2A patients obtained within different decades of lifetime. Color key corresponds to patient number.
Figure 5. Generation of ush2au507zebrafish. (A) Schematic representation of zebrafish and human usherin domain architecture. The u507 mark on zebrafish usherin
indicates the region targeted by CRISPR/Cas9. (B) Sanger sequencing traces showed the ush2a gene sequence change in homozygous ush2au507 mutant zebrafish
(c.2131_2203 + 73delinsCGGCGG) at the CRISPR/Cas9 target site. (C) Anti-usherin-C (red) and anti-centrin (green) immunostaining of retinal sections from wt and
ush2au507 larvae (5 dpf). DAPI nucleic acid stain was used as a counterstain (blue). PAM, protospacer adjacent motif. INL, inner nuclear layer; OPL, outer plexiform
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Figure 6. Visual function in ush2au507 zebrafish. (A) Normalized average b-wave amplitude of ERG responses recorded from wt and ush2au507 zebrafish at 5 days post
fertilization (wt: n = 69, ush2au507: n = 67). (B) Maximum b-wave amplitudes are plotted as bar graphs (mean ± SEM). (C) Visual acuity (cycles per degree, cpd) of wt and
ush2au507 zebrafish at 3 months post fertilization (mpf), 6 mpf and 12 mpf, assessed using the optokinetic response assay (n = 4–5, mean ± SEM). ∗∗P < 0.001. Mann
Whitney tests and two-way ANOVA were used to test for statistical significance in ERG and optokinetic response data, respectively.
and horizontal cells (Fig. 9C–G). These vesicles were not seen
in age-matched wt retinas.
A comparison between the previously published ush2armc1
mutant with the new ush2au507 line was undertaken to determine
optimal outcome measures for future therapeutic testing. The
ERG showed a stronger reduction of the b-wave amplitude in
the ush2armc1 mutant (10) and increased blue cone opsin mis-
localization compared to strain-matched wt (P < 0.01) (Supple-
mentary Material, Fig. S7). In ush2au507 larvae, no significant
blue cone opsin mislocalization was observed as compared to
strain-matched wt. Similarly, quantification of rhodopsin levels
in the photoreceptor cell body revealed significantly increased
rhodopsin mislocalization in the ush2armc1 retina compared to
controls (P < 0.05), but not in the retina of ush2au507 larvae.
Zebrafish ush2armc1 larvae (6 dpf) already showed significantly
increased rhodopsin mislocalization (P = 0.016) prior to exposure
of daily light levels (Fig. 10A); this was not found in wt controls.
Twenty minutes after light onset, wt larvae showed rhodopsin
mislocalization, which resolved by 100 min postlight onset; this
rescue was not observed in ush2armc1 mutants (P < 0.0001). Both
sample timing related to light exposure and the ush2a genotype
had a significant effect on the amount of rhodopsin mislocal-
ization (P < 0.0001). Levels of rhodopsin mislocalization coin-
cided with an increased number of autophagosomes in the
inner segment of ush2armc1 photoreceptors prior to light onset
(P < 0.05, Fig. 10B), which was visualized by antibodies directed
against autophagosome marker LC3. In wt larvae, the number of
LC3-positive photoreceptors increased shortly after light onset
and subsequently decreased to baseline levels by 100 min after
light onset but remained slightly elevated in ush2armc1 mutants
(P = 0.11). Both the timing of sampling and the ush2a genotype
were found to have a significant effect on the amount of LC3-
positive photoreceptors (P < 0.0001 and P < 0.01, respectively).
Expression of autophagy-associated genes atg5 and atg12 was
significantly increased in light-adapted ush2armc1 mutant lar-
vae compared to wt controls (Fig. 10C). Western blot analysis
revealed increased levels of lipidated autophagosomal mem-
brane protein LC3 (LC3 II), p62/SQSTM and beclin 1 in ush2armc1
larvae both before and after onset of light (Fig. 10D).
Discussion
This is the first longitudinal study for Usher syndrome type II
describing the retinal changes in a large USH2A patient cohort,
and comparing it to ush2a zebrafish models to identify reliable
therapeutic outcome measures for both preclinical and clinical
studies. Our choice of EZ and hyperAF rings follows recent
changes in Food and Drug Administration efficacy evaluation
(23). This change represents recognition of the variability present
in many functional markers such as visual acuity, microperime-
try and visual fields. Evaluation of several clinical parameters
showed that visual acuity did not change significantly over the
2–5 year follow-up period and retinal thickness was confounded
by macular edema, which was not consistent with degeneration
alone (Supplementary Material, Table S1). Neither of these
metrics are suitable indicators of potential change in retinal
function with disease progression, and thus, not suitable clinical
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Figure 7. Auditory function in ush2au507 larvae. (A) and (B) Macular hair cell cross-sections from 6 days post fertilization (dpf) wt and ush2au507 larvae were
immunostained with anti-acetylated tubulin (red), anti-usherin-N (green) and DAPI (blue). (C) and (D) Stereociliary hair bundles of the anterior macula in wt and
ush2au507 zebrafish at 6 days post fertilization stained with Alexa Fluor 647 Phalloidin. Bar graph (E) shows the number of hair cell bundles per anterior macula in wt
and ush2au507 larvae (mean ± SEM, n = 10). Bar graph (F) shows distance moved in response to acoustic stimuli of different frequencies (mean ± SEM, n ≥ 77 from three
biological replicates per group). An unpaired t-test or two-way ANOVA were used to test for statistical significance. ∗P < 0.05. Scale bars = 10 μm.
correlations between both the rate of change of the EZ length
constriction and the hyperAF ring area with age. However, when
evaluating the cohort for predictive value of these trends, it
is clear that the strong statistical significance results from
the large number of subjects. Considerable variability exists
in the populations, exemplified by low r value describing the
relationships. Therefore, trials aiming to predict future pro-
gression based on age-matched cohorts would require large
numbers of participants in order to account for this variability.
This is complicated by the fact that Usher syndrome is a slowly
progressive, rare disease with a limited number of patients
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Figure 8. Rod and cone opsin localization in the ush2au507 retina. Rhodopsin (A–D) and UV (E–H), red (I–L), green (M–P) and blue (Q–T) cone opsins were detected in the
wt and ush2au507 zebrafish retina at 6 months post fertilization (mpf), and 12 mpf by immunohistochemical analysis (red). In the 6 mpf ush2au507 retina, rhodopsin
was partially mislocalized in some regions where it was detected in parts of the rod photoreceptors other than the outer segment (arrows in B). In the 12 mpf mutant
retina, rhodopsin was more extensively mislocalized and expression in the rod outer segments was reduced compared to wt. Blue opsin was noted in the blue cone
inner segments (highlighted with a bracket) in the ush2au507 retina at 12 mpf (T). All sections are counterstained with DAPI nuclei acid stain (blue). Bar chart (U) shows
levels of rhodopsin detected in the rod outer segments at 6 and 12 mpf, measured using pixel intensity on confocal images (mean ± SEM. Three sections analyzed per
fish, n = 3 per age). Unpaired t-tests were used to compare wt and ush2au507 rhodopsin levels at each age. ∗P < 0.05, ∗∗P < 0.01. OPL, outer plexiform layer; ONL, outer
nuclear layer; RPE, retinal pigment epithelium. Scale bar = 25 μm.
treatment is difficult to predict. Previous gene therapy trials
have aimed at slowing or halting disease progression (rather
than attaining marked visual improvement). Although new
trials provide promise that improvement may be possible (24),
based on prevailing data both on acceptable endpoints and
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Figure 9. Retinal ultrastructure of ush2au507 zebrafish. Transmission electron microscopy was used to examine the wt and ush2au507 retinal ultrastructure at 6 months
post fertilization (mpf). The wt retina showed tiers of morphologically distinct cone and rod photoreceptors with overlying retinal pigment epithelium (RPE) with long
apical projections that interdigitated with the photoreceptors (A). Among mostly preserved tissue, regions of rod loss could be observed in the ush2au507 retina (B).
Presumptive lysosomal structures (blue arrows) were noted at the inner and outer segment boundary (D, E) and at the synapses (G) of the ush2au507 photoreceptors at
6 mpf. Ribbon synapses are indicated by ∗. These vesicles were not observed in wt photoreceptors (C, F). IS, inner segment; OS, outer segment; IS, inner segment; OS,
outer segment; RPE, retinal pigment epithelium; BM, Bruch’s membrane; N, nucleus; P, phagosome; M, melanosome. Scale bars = 5 μm (A, B, F, G) and 500 nm (C–E).
the strongest correlation and best repeatability However, taking
this a step further to evaluate its use for a trial, this correlation
only accounts for 44% of future variability. This means a trial
designed in a 2:1 treated to untreated ratio, as a function of age,
612 total subjects (408:204) would be required to detect an 80%
reduction in degeneration rate.
Furthermore, based on repeatability data, the trial would
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Figure 10. Rhodopsin mislocalization and elevated autophagy in ush2armc1 larvae. (A) Rhodopsin (red) was predominantly detected in the outer segment of wt
and ush2armc1 larvae at 6 dpf. The inner segments occasionally revealed rhodopsin immunofluorescence, indicative of mislocalized rhodopsin transport vesicles
(arrow). Representative images of dark-adapted larvae are shown for both genotypes. Quantification of the number of photoreceptors with distinct rhodopsin
immunofluorescence in the inner segment revealed increased rhodopsin mislocalization in ush2armc1 mutants. Two-way ANOVA revealed a significant interaction
between the moment of sampling and the genotype of the larvae (P = 0.0019), a significant difference in rhodopsin mislocalization between wt and ush2armc1 mutants
(P < 0.0001) and difference in rhodopsin mislocalization depending on moment of sampling (P < 0.0001). Bonferroni’s post-test was used to reveal differences between
groups (∗P < 0.05; ∗∗∗∗P < 0.0001). (B) LC3 immunoreactivity, a marker for autophagosome vesicles, could be observed in the periciliary region (arrow) and inner segment
(arrowhead) of a subset of photoreceptors. Representative images of dark-adapted larvae, are shown for both genotypes. Quantification of the number of photoreceptors
with distinct LC3 immunofluorescence in the inner segment revealed increased presence of autophagosomes in ush2armc1 mutants. Two-way ANOVA revealed no
significant interaction between the moment of sampling and the genotype of the larvae, a significant difference in LC3-positive photoreceptors between wt and
ush2armc1 mutants (P = 0.0078) and difference in LC3-positive photoreceptors depending on moment of sampling (P < 0.0001). Bonferroni’s post-test was used to reveal
differences between groups (∗P < 0.05). (C) Quantitative RT-PCR analysis of autophagy associated genes atg5 and atg12 in wt and ush2armc1 larvae. Two pools of 10 larvae
were used per genotype (∗P < 0.05, unpaired t-test). (D) Western blot analysis of pooled larvae, using antibodies directed at several markers of autophagy, revealed
differences in expression of these markers between wt and ush2armc1 mutants. Anti-actin was used as a loading control. OS, outer segments; ONL, outer nuclear layer;
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in a sufficient majority of patients. This detection of change and
rate do scale with the size of baseline measurement as shown by
the lack of taper in the repeatability data (Supplementary Mate-
rial, Fig. S3), suggesting that all measurements have equal error
and that absolute error does not change. Detection threshold
is fairly constant across sizes of measurement as evaluated in
actual values; however, if scaled as a percent of residual tissue,
the larger the baseline measurement the smaller the possible
error in detection. Additionally, degeneration is not linear with
age, with patients experiencing quicker and slower degeneration
rates at different stages of the disease. Therefore, trials designed
based on younger patients degenerating rapidly may provide
better possibility of success. We must await one of two results to
confidently design a future clinical trial: (i) multifaceted longi-
tudinal trials such as CRUSH and RUSH2A (NCT03146078), which
will provide more data points allowing multilinear regression
models to better inform proper endpoint and trial lengths and
(ii) new artificial-intelligence-based methods (25,26) to design
better predictors by using data on a particular solution to suggest
an improvement in a specific outcome, thus altering the model
away from simply reducing degeneration rate (20). It is likely
that new data relating to both phenotype and each drug will be
needed to accurately define future trials, due to differing targets
and mechanisms of drug action, such as restoring function or
slowing of progression. If gain of function is anticipated, trials
could be relatively short (between 12 and 18 months) to arrive at
an estimate of potential longevity. If slowing disease progression
is predicted, then the data herein can be used to model projec-
tion for the treatment.
The audiograms overall remained stable throughout the
life span of our relatively small patient cohort. This was
consistent with previously published data for type II Usher
syndrome (27), suggestive that audiometric outcomes are not
useful outcome measures for trials. A previous study reported
the presence of more severe hearing loss in the presence of
two protein-truncating mutations, including homozygotes for
the common c.2299delG mutation, than in those with non-
truncating changes (28). However, this was not observed in
our two patients with homozygous c.2299delG mutations, who
displayed stable moderate hearing loss. In contrast, case 6
with c.2299delG, p.(Glu767Serfs21∗) mutation and c.14911C>T,
p.(Arg4971∗) mutation had severe hearing loss from their first
decade of life that progressed to profound in the second decade
suggesting that additional factors may play a role in severity of
hearing loss. Further investigation in larger patient cohorts is
required to draw more consistent conclusions.
Potential defects in the auditory system in the newly devel-
oped ush2au507 mutant line were also investigated. Splayed stere-
ociliary bundles have been observed in the hair cells of several
Usher type 1 and 3 zebrafish models including myo7aa (29),
cdh23 (30), ush1c (31) and clrn1 (32), but this morphology was
relatively intact in the ush2au507 fish. At high frequencies, we
observed a reduction in acoustic startle response in ush2au507
larvae, although not statistically significant; this is inconsistent
with the findings in the TALENs-generated ush2a−/− mutant,
where acoustic startle responses were significantly reduced at
both ages examined (10 dpf and 6 mpf) (17). Measurements
taken from older ush2au507 fish, when the inner ear is further
developed, may be necessary to detect auditory defects. Auditory
function was not investigated in ush2armc1 and ush2ab1245 mutants
(10). Usherin is known to be transiently expressed in the stere-
ociliary ankle links of the inner ear hair cells, supporting normal
hair cell bundle development (14,15). Unless treatments can be
given early enough (in utero), post-natal therapeutic strategies
are unlikely to have a significant impact on hearing. Based
on the data from the USH2A cohort, and the mild stereocilia
phenotype of the zebrafish, it is difficult to determine good
outcome metrics of therapeutic effect on auditory function at
this moment. Additional tests such as otoacoustic emission and
electrocochleography/auditory brainstem response in patients,
or microphonic potential recordings in zebrafish, may provide a
more detailed analysis of hair cell function (33,34).
Several USH2A animal models exist and have been character-
ized including the Ush2a null mouse (8) and zebrafish mutants
(10,17). While these models have added to our understanding of
the USH2A pathophysiology, the molecular pathways underlying
retinal degeneration have not yet been elucidated. In Ush2a null
mice, first evidence of retinal degeneration was observed at
20 months of age (8). In contrast, previously published zebrafish
models (ush2armc1, ush2ab1245 and ush2ahzu6) displayed early
defects in retinal function (10,17). Unlike the ush2armc1 and
ush2ab1245 mutants (10), the ush2au507 zebrafish line presented
here displayed a slowly progressive retinal degeneration,
evidenced by an increased number of apoptotic photoreceptors
and loss of ONL nuclei with age. Progressive degeneration
was mentioned in the ush2ahzu6 line (17), but their conclusions
were only based on gross changes in retinal morphology. ERG
recordings of ush2au507 larvae revealed a decrease in b-wave
amplitude that is similar to that measured in ush2ahzu6 larvae,
but milder as compared to ush2armc1 larvae.
Following the observed decrease in retinal function and reti-
nal degeneration in ush2au507 zebrafish, the molecular defects
resulting from loss of usherin function were further examined.
Usherin was previously shown to be localized at the periciliary
membrane of the photoreceptor cells, interacting with other
USH2 proteins to form a complex that is hypothesized to con-
tribute to the transfer of cargo, such as rhodopsin, from inner
segment transport carriers to the ciliary transport system (9).
This periciliary protein network was originally identified in frog
photoreceptors, in an analogous area called the periciliary ridge
complex (35), considered to be a docking site of vesicles trans-
porting newly synthesized rhodopsin from the Golgi. Mislocal-
ization of rhodopsin and blue cone opsin found in the ush2au507
retina contrasts with the findings from the ush2ahzu6 mutant,
which did not show photopigment mislocalization at any age
(17), and ush2armc1 and ush2ab1245 were not previously investi-
gated for transport defects (10). Defective rhodopsin trafficking is
consistent with the proposed impaired function of the periciliary
membrane complex. In whirler mouse (Usher syndrome type 2D)
photoreceptors, rhodopsin was found to be mislocalized (36), as
were both rhodopsin and blue cone opsin in Myo7a mutant mice
(Usher syndrome type 1B) (36,37) and zebrafish (38). The proteins
encoded by these mutant genes, whirlin and myosin VIIA, are
among several Usher syndrome proteins found to interact with
usherin at the mouse periciliary membrane complex (9,39). The
high degree of similarity in opsin and rhodopsin mislocaliza-
tion phenotypes between Usher models is unsurprising, as N-
terminal protein-truncating mutations in ush2a were previously
shown to result in loss of all members of the USH2 protein com-
plex from the periciliary membrane complex (10). However, in
contrast to the ush2au507 zebrafish retina, the Ush2a mouse was
found to have normal rhodopsin labeling while red-green cone
opsin staining showed mislocalization by p80 (40). The reason for
this species discrepancy is unknown. Herein, further study of the
ush2armc1 retina has revealed mislocalization of rhodopsin and
blue cone opsin in larval stages, suggesting a more severe phe-
notype possibly linked to genotype or the genetic background
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reported that rhodopsin preferentially enters the photoreceptor
outer segment in the dark in wt retinae (41); however, the higher
levels of mislocalization in ush2armc1 mutants sampled in the
dark with persistence following light exposure indicates that
photoreceptors are not able to elicit a proper cellular response.
Previous data indicate that autophagy plays a crucial role in
maintaining photoreceptor health by degrading the excess of
phototransduction proteins, preventing their toxic accumulation
in the inner segment, which would otherwise cause retinal
degeneration (42–45). An increase of autophagosomes in the
ush2armc1 mutant retina prior to onset of light, combined with the
increased expression of beclin1, which is essential for the pack-
aging of autophagic proteins to a pre-autophagosomal structure
(46), and the upregulation of the expression of the autophagy-
associated genes atg5 and atg12, suggests that autophagy is
induced in response to rhodopsin mislocalization (47). How-
ever, the stabilization of p62 (Sequestosome-1/Sqstm), a selective
autophagy receptor for ubiquitinated proteins that is normally
degraded through autophagy along with its ligands, indicates
that lysosomal degradation of autophagosomes could be ham-
pered (47), and may explain the persistence of mislocalized
rhodopsin following light exposure. The inability of ush2armc1
photoreceptors to recover in the dark, and/or the constant con-
sumption of excess energy to facility this recovery, is hypothe-
sized to progressively induce pro-apoptotic signaling and retinal
degeneration.
Examination of the retinal ultrastructure of the ush2au507
mutant revealed the presence of vesicular structures with the
appearance of lysosomes around the photoreceptor inner and
outer segment boundary and at the synaptic termini. While
this could be interpreted as lysosomes functioning at the max-
imum of their capacity in the ush2a-deficient retina, further
investigation is necessary. The observed changes in autophagy
parameters could also occur when fusion of autophagosomes
with lysosomes is defective. While many cellular stress path-
ways sequentially induce autophagy (at early time points to
overcome cellular stress) and apoptosis (at late time points with
high/prolonged cellular stress), the overall design of autophagy–
apoptosis crosstalk is highly complex and primarily aims to
reduce cell death (48).
Rhodopsin mislocalization and autophagy are useful func-
tional outcome measures for monitoring response to treatment
in preclinical zebrafish ush2a models. They also provide targets
for small molecule drug development, but a careful balance is
required to prevent activation of pro-apoptotic signaling path-
ways associated with high levels of cellular stress. The effect of
light on rhodopsin transport and the subsequent intracellular
responses indicate that a proper comparison between different
mutant lines is only feasible when animals are raised under the
exact same conditions. However, modulating the light intensity
and regime provides the opportunity to increase the resolution
of therapeutic experiments, for example in high-throughput
drug discovery approaches.
In summary, due to more detailed phenotypic analysis of
the ush2a mutant zebrafish retina, new insights into USH2A-
related retinal disease have been gained, including photopig-
ment mislocalization, elevated autophagy and subcellular traf-
ficking defects, in keeping with other models of Usher syndrome.
Therapeutic outcome measures would ideally include assess-
ment of retinal function such as ERG recordings, analysis of
rhodopsin and blue cone opsin mislocalization and autophagy.
For patients, multimodal retinal imaging approaches may be
the most sensitive measure of change, but prospective deep
phenotyping studies will provide greater insights into the key




Potential subjects were identified from the prospectively con-
sented Moorfields Eye Hospital Inherited Eye Disease Database
for structure/function of genetic diseases. This ongoing study
is designed to facilitate discovery of new genes and aggregate
data for longitudinal phenotype studies. Data for these studies
are collected as part of standard of care and retrospectively ana-
lyzed. From this database, 56 USH2A-associated Usher Syndrome
patients with molecularly confirmed biallelic USH2A mutations
with at least three clinical visits close to a year between each visit
(average 15 months between visits, range 9–51 months) were
identified. A complete eye examination was performed in all
subjects, including BCVA (converted to decimal units to facilitate
comparison) and retinal imaging.
Retinal imaging
Spectral domain optical coherence tomography (SD-OCT), (19 B-
scans, 512 A-scans/B-scans; 97 B-scans, 1024 A-scans/B-scans)
and fundus autofluorescence (FAF) imaging was performed on
all patients using the Heidelberg Spectralis (Heidelberg Engineer-
ing, Heidelberg, Germany) with Automated Retinal Tracking. As
this was a retrospective cohort, scan protocols were determined
by the treating clinician at each visit and would receive one but
not both scanning protocols. From these volumes the central SD-
OCT B scan was identified by a trained observer as having the
least residual inner retinal tissue and thickest ONL presence.
For analysis, only scans with at least 500 μm of residual EZ
present at baseline, but not so intact that it extended beyond the
edges of the scan were included. FAF imaging was done using
full power, blue light autofluorescence using the Heidelberg
Spectralis (Heidelberg Engineering, Heidelberg, Germany) at 30
or 55◦ depending on which best visualized the residual FAF area.
All images were analyzed with Heidelberg Eye Explorer
Region Finder Version 2.4.3.0 (Supplementary Material, Fig.
S1) for measurements of retinal thickness and intact retinal
area. The hyperautofluorescent (hyperAF) ring area as well
as horizontal and vertical widths were manually segmented
(Supplementary Material, Fig. S1D). All grading was done by two
trained graders to ensure repeatability (Supplementary Material,
Fig. S3).
Audiology
Eleven patients had their pure tone audiograms undertaken by
their local audiology service according to the British Society of
Audiology recommended procedures (49). The pure tone average
(PTA), which indicates the hearing level of the patient was cal-
culated by averaging the hearing threshold in decibels hearing
level (dB HL) at 500, 1000, 2000 and 4000 Hz frequencies. The level
of hearing loss is categorized according to the PTA level as mild
hearing loss 20–40 dB HL, moderate hearing loss 41–70, severe
hearing loss 71–95 and profound hearing loss >95 dB HL. The
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Zebrafish husbandry
Zebrafish [wt, AB-strain (wt) and ush2au507] were bred and
maintained at the UCL Institute of Ophthalmology animal
facility. wt and ush2au507 zebrafish were generated by pair-wise
matings of genotyped homozygous fish and raised at 28.5◦C
on a 14 h light/10 h dark cycle. Zebrafish [wt, TL-strain (wt)
and ush2armc1] were generated and maintained as previously
described (10). Heterozygous ush2a zebrafish were not examined
in this study. Developing embryos were staged in days post
fertilization (dpf) as previously described (50). For terminal
experimentation, zebrafish were anaesthetized in 0.2 mg/ml
Tricaine (MS-222, Western Chemical Inc., Scottsdale, AZ, USA)
and euthanized under schedule 1.
CRISPR/Cas9 mutagenesis
To generate the ush2au507 mutant zebrafish, CRISPR targets were
identified using an online software tool (https://zlab.bio/guide-
design-resources) and the following 20 bp target guide sequence
in ush2a exon 12 was chosen: 5′-AATATCTGGCTGCACGGTCC-3′.
A cloning-free method similar to that reported in Gagnon et al.
was used to synthesize the sgRNA (51). The Cas9 plasmid pT3Ts-
nCas9n (Addgene #46757) was used as a template for Cas9 mRNA
synthesis. A solution of 150 ng/μl Cas9 mRNA and 75 ng/μl sgRNA
was co-injected into the cell of one-cell stage embryos from wt
breedings, using a Picospritzer III microinjector (Intracel, Herts,
UK). A dose volume of approximately 1 nl was used for injection.
To verify the mutagenesis activity of the sgRNA, genomic
DNA was extracted from injected embryos at 24 hpf followed
by PCR amplification of the region containing the target site.
To extract DNA, de-chorionated embryos were incubated for
3 h at 50◦C in DNA extraction buffer consisting of: 10 mm Tris
(pH 8.2), 300 mm NaCl, 0.5% SDS, 200 μg/μl proteinase K and
10 mm EDTA. An ush2a DNA sequence of 652 bp containing the
CRISPR target site was PCR amplified from the samples using
MyTaq DNA polymerase (Bioline, London, UK) with the ush2a
exon 12 primers, which spanned the target site. The sequences
were as follows: 5′-GAGACCCATTCTGTTAAAGCACC-3′ and 5′-
TCCCAGTTTGGCATTGCAGATC-3′. The cycle conditions used
were: incubation at 95◦C for 1 min for initial denaturation,
followed by 35 cycles of 95◦C for 15 s (denaturation), 61◦C
for 15 s (annealing) and 72◦C for 10 s (extension). Samples
were analyzed using Sanger sequencing. When mutations were
detected, batches of injected embryos were raised to adulthood.
F0 fish that transmitted germline mutations were outcrossed
with wt fish. Heterozygous F1 progeny that were identified
as possessing frameshift mutations were outcrossed with wt
fish. F2 heterozygous fish carrying the same mutation were
incrossed to produce F3 progeny. Homozygous fish and their
wt siblings were used for subsequent breeding and phenotypic
characterization.
RNAscope assay
Enucleated adult zebrafish eyes (∼6 months post fertilization,
mpf), or whole 6 dpf larvae, were fixed in 4% PFA/PBS at 4◦C
overnight. After washing three times in PBS for 10 min, the
eyes/larvae were incubated in 10, 20 and 30% sucrose/PBS at 4◦C
overnight each time. The samples were embedded in Tissue-Tek
O.C.T embedding medium (VWR, Radnor, PA, USA) using dry ice
and 12 μm sections were collected onto Superfrost
®
PLUS slides
(VWR) using a Leica CM1850 cryostat. The RNAscope assay was
performed using the RNAscope Fluorescent Multiplex Detection
v2 kit (ACD) as previously described (52). The ush2a target probe
and odc1 and dapB control probes were designed and provided by
ACD.
Retinal histology
For histological evaluation, enucleated eyes were fixed in 4%
paraformaldehyde/PBS at 4◦C overnight before processing and
embedding using the JB-4TM embedding kit (Polysciences Inc.,
Warrington, PA, USA) with 7 μm thick sections as described (53).
Sections were imaged on a Leica DMRB with Jenoptik D-07739
Optical System. Numbers of nuclei in the ONL were counted
from histology sections that contained optic nerve, using ImageJ
(National Institutes of Health, Bethesda, MD, USA).
TUNEL assay
Fresh enucleated eyes were fixed with 4% PFA/PBS overnight at
4◦C before incubation in 30% sucrose/PBS for 6 h at room tem-
perature. The samples were mounted and frozen in TissueTek
O.C.T using dry ice. About, 12 μm sections were cut using a Leica
CM1850 cryostat and collected onto Superfrost
®
PLUS slides. The
TUNEL assay was performed as previously described (53) using
the ApopTag
®
Plus Fluorescein In Situ Apoptosis Detection Kit
(Merck-Millipore, Burlington, MA, USA). Images were taken on
a Zeiss LSM 700 AxioImage M.1 upright microscope. At least
three retinal sections were assessed for the number of apoptotic
photoreceptor nuclei per fish.
Immunohistochemistry
Cryosections were prepared from adult enucleated eyes or whole
larvae and immunostained as previously described (10,52). Pri-
mary antibodies used were 4D2 (1:200; Abcam, Cambridge, UK;
ab98887), anti-UV opsin, anti-blue opsin, anti-red opsin (1:200;
gifted by Professor David Hyde, University of Notre Dame), anti-
usherin-C (1:500; Novus Biological, Littleton, CO, USA; 27 640 002),
anti-usherin-N (1:200; gifted by Dr Jennifer Phillips, University
of Oregon), anti-LC3 (1:200; Thermo Fisher Scientific, Waltham,
MA, USA; PA1-16930), anti-centrin (1:500; Merck-Millipore; 04-
1624) or anti-acetylated tubulin (1:200; Sigma-Aldrich, St Louis,
MO, USA; T7451). Primary antibodies and appropriate secondary
Alexa Fluor antibodies (1:500; Thermo Fisher Scientific) were
diluted in antibody solution. The slides were imaged using a
Leica LSM 700 confocal microscope or a Zeiss Axio Imager fluo-
rescence microscope equipped with an Axiocam MRC5 camera.
Rhodopsin levels were quantified using ImageJ. For this, all pic-
tures were taken using the same settings after which the region
of interest (adult retina: rod outer segments, larval retina: inner
segment and ONL) was defined manually and assessed using the
mean pixel intensity measurement.
Western blot of autophagy markers
Pools of 50 larvae per group were sampled on ice in lysis buffer
[2% Triton X-100 in Tris-Buffered Saline (TBS), pH 7.4, supple-
mented with protease inhibitor cocktail (Roche)], and homog-
enized using a pestle, and multiple passes through a small-
gauge needle. Next, 13 μl of sample was mixed with 5 μl loading
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and incubated for 10 min at 70◦C. Samples were separated on a
4–12% SDS-Page gel (Thermo Fisher Scientific) and transferred
to a nitrocellulose membrane. For immunoblotting, the mem-
brane was blocked with 5% blotting grade block buffer (Bio-
Rad, Hercules, CA, USA) in PBS for 1 h at room temperature,
after which primary antibodies were incubated in 0.5% blocking
buffer overnight at 4◦C. After washing three times with PBS
supplemented with 0.2% Tween-20, the membrane was incu-
bated with Alexa Fluor 680 or 800-conjugated secondary anti-
bodies (Thermo Fisher Scientific, A21057, A21076 and LI-COR
Biosciences, 926-32210) for 45 min at room temperature. After
washing three times with PBS 0.2% Tween-20 and several rinses
in PBS, membrane was scanned using the Odyssey CLx scan-
ner (LI-COR Biosciences). The primary antibodies used were
anti-LC3 (1:1000; Thermo Fisher Scientific; PA1-16930), anti-actin
(1:2000; Abcam; ab3280), anti-P62 (1:1000; Cell Signaling Tech-
nology, Danvers, MA, USA; 5114T) and anti-BECN1 (1:1000; Santa
Cruz, Dallas, TX, USA; sc-11 427).
Electron microscopy
For transmission electron microscopy, enucleated zebrafish eyes
were fixed in 2% paraformaldehyde-2% glutaraldehyde prior
to incubation with 1% osmium tetroxide-1% potassium ferro-
cyanide. Following dehydration in an ethanol series and propy-
lene oxide, the zebrafish were embedded in Epon 812 resin.
Using a Leica EM UC7 ultramicrotome, 100 nm sections were cut,
collected on formvar-coated copper grids (Electron Microscopy
Sciences, Hatfield, PA, USA) and stained with lead citrate (Agar
Scientific, Stansted, UK). Sections were examined on a Jeol 1010
TEM and imaged using a Gatan Orius SC1000B charge-coupled
device camera.
For scanning electron microscopy, whole 6 dpf larvae were
fixed and dehydrated as above. Samples were incubated twice
in anhydrous methanol before hexamethyldisilazane (Sigma-
Aldrich) incubation and overnight drying on watch glasses. Sam-
ples were mounted on stubs (Agar Scientific) and painted with
conductive silver paint (Agar Scientific) and left to dry overnight
before sputter-coating with gold/palladium using a Cressing-
ton Sputter Coater. Larval neuromasts were imaged on a Zeiss
Sigma VP.
Optokinetic response analysis
Adult zebrafish were lightly anaesthetized in 0.2 mg/ml tricaine
and placed in a custom-made foam holder supported by dis-
section pins in a 55 mm petri dish. The dish was filled with
tank water and the fish were allowed to regain consciousness,
then placed into a custom-made optokinetic device consisting
of a 12 cm acrylic drum, rpm adjustable rotating motor with
laser tachometer and stereo microscope (Zeiss Stemi-2000C) c-
mounted with a digital SLR camera (Nikon D5100). Each zebrafish
was assessed with varying grating lengths at a consistent rpm
speed (12 rpm) until the stripes could no longer be tracked by
the zebrafish, as previously described (52).
ERG recordings
ERG recordings were performed on isolated larval eyes (5 dpf) as
previously described (10). Briefly, larvae were dark-adapted for
a minimum of 30 min prior to measurement and subsequently
handled under dim red illumination. The electrode was filled
with E3 embryo medium (5 mm NaCl, 0.17 mm KCl, 0.33 mm CaCl,
and 0.33 mm MgSO4) and positioned at the center of the cornea.
A white light pulse (pE-4000, CoolLED) of 100 ms duration, with a
light intensity of 600 lux was provided. Electronic signals were
amplified 1000 times by an amplifier (EXT-02F, NPI electronic
Instruments, Tamm, Germany) with a band pass between 0.1 and
700 Hz, digitized with Micro1401-3 (Cambridge Electronic Design
Limited, Cambridge, UK) and displayed in Signal 6.03 (Cambridge
Electronic Design Limited). The response to three consecutive
pulses was averaged for each eye.
Wholemount phalloidin staining of zebrafish larvae
Larval zebrafish at 6 dpf were fixed with 4% PFA/PBS overnight
at 4◦C. Zebrafish were washed in PBS for 10 min and incubated
in PBS/1% Triton-X for 4 days to dissolve the otoliths. The larvae
were washed three times for 10 min in PBS/1% Triton-X before
incubating for 2 h at room temperature with Alexa Fluor 647
Phalloidin (Thermo Fisher Scientific) diluted 1:10 in 2% normal
goat serum in PBS/0.5% Triton-X. The larvae were washed twice
for 10 min in PBS/1% Triton-X before mounting in Prolong Gold
Antifade Mountant on self-made multiwell microscope slides.
Fluorescent hair bundles were visualized using Zeiss LSM 700
AxioImage M.1 upright confocal microscope.
Acoustic startle response analysis
Experiments were performed using a vibration module and fast
camera system (Viewpoint Life Sciences, Civrieux, France). The
vibration module has a frequency range of 20–20 000 Hz, with
variable intensities generated through a 40 W amplifier. The
vibration time, duration and frequency were programmed using
Audacity software (54). The vibration stimulus is synchronized
with an infrared LED signal detected by the 1000 fps cam-
era (Baumer, Frauenfeld, Switzerland) and automated software
detects the C and S- start response of each fish in the well, as
described in (55). A blinded study was used with wt and mutant
groups at 5 dpf. Ten larvae were placed in each of 3 wells of a 6-
well microtiter plate. A sequence of pure tone stimulations with
frequencies of 600, 100, 900, 300 and 1200 Hz were generated.
Each tone lasted 100 ms with a gap between each tone of 100 s,
to avoid habituation. The response to each sound was recorded
at 1000 fps and measurement of distance moved (mm) was
performed by the Viewpoint software. The tone sequence was
performed at the lower level able to produce a robust C-start
response in wt fish.
FM1–43 uptake
Long-term dye incorporation experiments were performed as
described previously (56). Briefly, 6 dpf zebrafish larvae were
pre-incubated for 10 min in BAPTA (Thermo Fisher Scientific) to
disrupt the tip links and thus block FM1–43 entrance through
the mechanotransduction channels, and then for 90 min with
3 μm of FM1–43FX (Thermo Fisher Scientific’) in the presence of
low BAPTA concentrations for assessment of vesicle endocytosis.
After several washes, animals were fixed with 4% PFA, counter-
stained with phalloidin and processed for fluorescence analyses.
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Autophagy gene expression analysis
Per genotype, RNA was extracted from 2 pools of 10 larvae
(5 dpf) using Trizol reagent (Thermo Fisher Scientific) accord-
ing to manufacturer’s instructions. RNA was further purified
and DNase-treated using nucleospin RNA kit (Machery Nagel,
Düren, Germany). Reverse transcription was performed with
Superscript II (Thermo Fisher Scientific) in combination with
random hexamers (Thermo Fisher Scientific) and RNaseOUT
(Thermo Fisher Scientific). Quantitative RT-PCR was performed
on a Biorad CFX-96 real-time PCR machine, using 5× diluted
cDNA and GoTaq DNA polymerase (Promega, Madison, WI, USA).
Primer sequences used are provided in Supplementary Material,
Table S3.
Statistics
Given the high degree of interocular symmetry in human data,
the eye with the largest measurement baseline was used for all
further analyses. To assess progression rate for each parameter,
decline rates were binned by decade of age and averaged. Most
measurements occurred at yearly increments; for those that
were not, decline was assumed to be linear over the period of
time between observations and therefore change was divided by
time and rate of change/year was calculated. Pearson correla-
tions were used to assess the relatedness between progression
rates and parameters. All statistical analyses were done using
JMP 13 (SAS Institute, Inc., Cary, NC, USA). Zebrafish data were
shown as mean values ± SEM from n observations. The Shapiro–
Wilk test was used to test for normal distribution. Student’s t-
tests or Mann-Whitney U tests were used for single compar-
isons and two-way ANOVA followed by Bonferroni’s test was
performed for multiple comparisons. P < 0.05 was accepted to
indicate statistical significance (∗). GraphPad Prism software was
used for statistical analysis.
Study approval
The patient study protocol adhered to the tenets of the
Declaration of Helsinki and received approval from the NRES
Ethics Committee (REC12/LO/0141). Written informed consent
was obtained from all participating individuals prior to inclusion
in study.
Zebrafish were maintained according to institutional regu-
lations for the care and use of laboratory animals under the
UK Animals Scientific Procedures Act (UCL Institute of Ophthal-
mology animal facility) and Dutch experiments on animals act
(Radboud University Medical Center), UCL Animal Welfare and
Ethical Review Body (License no. PPL PC916FDE7) and Animal
Experiment Committee of the Radboud University Nijmegen
(License no. RU-DEC, 2012-301). All approved standard protocols
followed the guidelines of the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research Ethics.
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